For US residents only.

Patient Stories

TASIGNA

Hear from those living with Ph+ CML

Few things can be more empowering and motivating than hearing the stories of others who are taking on the challenges of Ph+ CML. We’ve engaged award-winning filmmakers to tell the stories of different people at various stages of the Ph+ CML journey who are taking TASIGNA® (nilotinib) capsules. Learn how they’re managing the various aspects of this condition, from treatment and testing to working and relationships. Share their frustrations and triumphs, and be inspired by their determination and resilience.

Meet Virginia

When Virginia was diagnosed with Ph+ CML in 2010, her doctor prescribed GLEEVEC® (imatinib mesylate) tablets. After she did not achieve sufficient response, her doctor switched her medication to TASIGNA. With the support of her family and friends, Virginia has maintained the active lifestyle she had before her Ph+ CML diagnosis.

Virginia is a real patient taking TASIGNA for Ph+ CML and was compensated by Novartis for her participation in the Ph+ CML Stories Series.

Meet Virginia

When Virginia was diagnosed with Ph+ CML in 2010, her doctor prescribed GLEEVEC® (imatinib mesylate) tablets. After she did not achieve sufficient response, her doctor switched her medication to TASIGNA. With the support of her family and friends, Virginia has maintained the active lifestyle she had before her Ph+ CML diagnosis.

Virginia is a real patient taking TASIGNA for Ph+ CML and was compensated by Novartis for her participation in the Ph+ CML Stories Series.

Meet Brian

Brian Boyle is a professional hockey player who has goals both on and off the ice. One of his biggest: Living a full life with Ph+ CML. After being diagnosed in 2017, Brian started on TASIGNA. Even with his demanding job and travel schedule, Brian makes taking TASIGNA a daily priority. Brian shares his story and is joined by a respected hematologist, Dr Anthony Botti.

Brian is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for his participation in the Ph+ CML Stories Series.

Meet Brian

Brian Boyle is a professional hockey player who has goals both on and off the ice. One of his biggest: Living a full life with Ph+ CML. After being diagnosed in 2017, Brian started on TASIGNA. Even with his demanding job and travel schedule, Brian makes taking TASIGNA a daily priority. Brian shares his story and is joined by a respected hematologist, Dr Anthony Botti.

Brian is a real patient taking TASIGNA for Ph+ CML in chronic phase and was compensated by Novartis for his participation in the Ph+ CML Stories Series.

Meet Robert

Robert was a 26-year-old newlywed when he was diagnosed with Ph+ CML. He and his wife questioned whether the future they dreamed of would still be possible. Now a father of 2, Robert relies on his sense of humor and his love of family to help him cope with the fear brought on by his Ph+ CML diagnosis.

Robert is a real patient taking TASIGNA for Ph+ CML and was compensated by Novartis for his participation in the Ph+ CML Stories Series.

Meet Robert

Robert was a 26-year-old newlywed when he was diagnosed with Ph+ CML. He and his wife questioned whether the future they dreamed of would still be possible. Now a father of 2, Robert relies on his sense of humor and his love of family to help him cope with the fear brought on by his Ph+ CML diagnosis.

Robert is a real patient taking TASIGNA for Ph+ CML and was compensated by Novartis for his participation in the Ph+ CML Stories Series.

Meet Russ

Looking back after his Ph+ CML diagnosis, Russ realized he had been tired and sleeping more for some time before the sudden abdominal pain that sent him to the hospital. Learning that he had Ph+ CML was difficult, but letting his students down was not an option. Russ has remained committed to their education and his own.

Russ is a real patient taking TASIGNA for Ph+ CML and was compensated by Novartis for his participation in the Ph+ CML Stories Series.

Meet Russ

Looking back after his Ph+ CML diagnosis, Russ realized he had been tired and sleeping more for some time before the sudden abdominal pain that sent him to the hospital. Learning that he had Ph+ CML was difficult, but letting his students down was not an option. Russ has remained committed to their education and his own.

Russ is a real patient taking TASIGNA for Ph+ CML and was compensated by Novartis for his participation in the Ph+ CML Stories Series.